UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2024
Commission File Number: 001-41661
JIN MEDICAL INTERNATIONAL LTD.
(Exact name of registrant as specified in its charter)
No. 33 Lingxiang Road, Wujin District
Changzhou City, Jiangsu Province
People’s Republic of China
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On October 10, 2024, Jin Medical International Limited issued a press release entitled “JinMed New Manufacturing Facility Initiation at Chuzhou China”, a copy of which is attached to this Form 6-K as Exhibit 99.1.
EXHIBIT INDEX
| Exhibit No. | Description | |
| 99.1 | Press Release issued by Jin Medical International Ltd., titled “Construction of JinMed’s New Facility Begins in Chuzhou, China”, dated October 10, 2024 |
1
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
JIN MEDICAL INTERNATIONAL LTD. | ||
| Date: October 11, 2024 | By: | /s/ Erqi Wang |
| Erqi Wang | ||
| Chief Executive Officer | ||
2